Nagao et al. (2017) studied the expression of p53 and Ki67 in response to chemoprevention of oral leukoplakia and reported that the expression of p53 is inversely associated with the clinical response to supplements administered for the condition. The gene discussed is MKI67; the disease is Oral leukoplakia.